Enzo Biochem, Inc. (ENZB)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Kara Cannon | CEO & Director | 714.35k | -- | 1970 |
Ms. Patricia Eckert CPA | Chief Financial Officer | 389.29k | -- | 1978 |
Enzo Biochem, Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 125
Description
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.
Corporate Governance
Upcoming Events
June 11, 2025 at 10:59 AM UTC - June 16, 2025 at 12:00 PM UTC
Enzo Biochem, Inc. Earnings Date
Recent Events
November 15, 2024 at 12:00 AM UTC
Ex-Dividend Date